claim
Chemotherapeutic agents including etoposide (NCT00878449), irinotecan (NCT01009073), cisplatin (NCT00878449), paclitaxel (NCT00891605), docetaxel (NCT00888108), and gemcitabine (NCT00887757) have been tested in combination with navitoclax to treat various cancers.

Authors

Sources

Referenced by nodes (1)